Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
Biological and translational evidence is synthesized to examine factors that may constrain the clinical efficacy of GPC3-targeted therapies, including antigen-related features, tumor microenvironment–associated barriers, and platform-specific challenges.